TrialBMC endocrine disorders2026

Alternate-day alternating monotherapy (q48h) versus daily concomitant atorvastatin-fenofibrate in adults with type 2 diabetes and mixed dyslipidemia: a 12-week randomized non-inferiority trial.

Soheil Shahramirad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.